ALTIMMUNE, INC. Loss Contingency, Estimate of Possible Loss
ALTIMMUNE, INC. (ALT) had Loss Contingency, Estimate of Possible Loss of $113.10 million as of 2015-01-31, per its 10-K filed 2017-03-14.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyEstimateOfPossibleLoss · last filed 2017-03-14
- 2015-01-31: Loss Contingency, Estimate of Possible Loss $113.10M.
- 2015-01-15: Loss Contingency, Estimate of Possible Loss $113.10M.
- 2015-01-07: Loss Contingency, Estimate of Possible Loss $113.00M.
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2015-01-31 | $113.10M 10-K · filed 2017-03-14 |
| 2015-01-15 | $113.10M 10-Q · filed 2015-11-06 |
| 2015-01-07 | $113.00M 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |